[Clinical study of method of strengthening body resistance and disintoxication disintoxication in patients with HCC of post-TACE].
OBJECTIVE
To research the effect of a complex prescription of Chinese crude drug with the function of strengthening body resistance and disintoxication disintoxication in patients with HCC of post-TACE.


METHODS
45 patients with HCC of post-TACE, as the treatment group, were treated by a complex prescription of Chinese crude drug with the function of strengthening body resistance and disintoxication disintoxication and routine methods of protecting liver. Other 37 patients, as the control group, with the same clinical feature were treated by routine methods of protecting liver only. In the later 1 month, accumulated points of clinical symptom, hepatic function and AFP were observed in all of the patients. And the clinical effect of the two groups was compared.


RESULTS
One week later, in the treatment group, there is no improvement in anorexia but nausea, abdominal distention and lassitude were improved more obviously than pretherapy in both a week and one month later (P < 0.01 or P <0.05). In the control group, anorexia were improved a week later (P <0.05), but there is no improvement in nausea, abdominal distention and lassitude at the same time, and one month later all of the indexes above improved (P <0.01 or P <0.05). Accumulated points of clinical symptom was decreased more obviously in the treatment group than in the control group in both a week and one month later (P <0.05). At the end of the therapy, in the both groups, ALT, TBIL and AFP all improved except ALB, (P <0.01 or P <0.05). And TBIL improved more obviously in the treatment group than in the control one month later (P <0.05).


CONCLUSIONS
This complex prescription of Chinese crude drug can lighten the adverse reaction of post-TACE. And also it can promote the recovery of liver function and evaluate the quality of lives of such patients.
Chen
Ze-xiong
ZX
The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China. zexiong333@163.com
Zhang
Shi-jun
SJ
Hu
Hong-tao
HT
Sun
Bao-guo
BG
Yin
Li-rong
LR
D000855:Anorexia / Q000188:drug therapy* / Q000209:etiology; D006528:Carcinoma, Hepatocellular / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects / Q000379:methods; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal / Q000302:isolation & purification / Q000627:therapeutic use*; D005221:Fatigue / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000628:therapy; D008297:Male; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology; D008517:Phytotherapy; D010946:Plants, Medicinal / Q000737:chemistry; D016896:Treatment Outcome; D000509:alpha-Fetoproteins / Q000378:metabolism